Published in EMBO J on May 15, 2002
Vps27 recruits ESCRT machinery to endosomes during MVB sorting. J Cell Biol (2003) 3.68
Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J Cell Biol (2003) 3.07
Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. J Virol (2003) 3.05
TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation. Proc Natl Acad Sci U S A (2003) 2.46
HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. J Cell Biol (2003) 2.38
Nedd4 regulates egress of Ebola virus-like particles from host cells. J Virol (2003) 2.19
Vps27-Hse1 and ESCRT-I complexes cooperate to increase efficiency of sorting ubiquitinated proteins at the endosome. J Cell Biol (2003) 2.17
The intrinsic affinity between E2 and the Cys domain of E1 in ubiquitin-like modifications. Mol Cell (2007) 2.05
Bro1 coordinates deubiquitination in the multivesicular body pathway by recruiting Doa4 to endosomes. J Cell Biol (2004) 1.93
Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression. J Virol (2003) 1.79
Spongiform neurodegeneration-associated E3 ligase Mahogunin ubiquitylates TSG101 and regulates endosomal trafficking. Mol Biol Cell (2007) 1.75
The ubiquitin-proteasome system of Saccharomyces cerevisiae. Genetics (2012) 1.73
Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding. Genes Dev (2004) 1.73
Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc Natl Acad Sci U S A (2012) 1.72
Structure and ubiquitin interactions of the conserved zinc finger domain of Npl4. J Biol Chem (2003) 1.72
NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. J Virol (2008) 1.60
Late domain-dependent inhibition of equine infectious anemia virus budding. J Virol (2004) 1.57
Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release. J Virol (2003) 1.56
Essential role of ubiquitin and TSG101 protein in formation and function of the central supramolecular activation cluster. Immunity (2010) 1.56
How ubiquitin functions with ESCRTs. Traffic (2011) 1.51
Novel approaches to inhibiting HIV-1 replication. Antiviral Res (2009) 1.48
ESCRT ubiquitin-binding domains function cooperatively during MVB cargo sorting. J Cell Biol (2009) 1.47
In vitro budding of intralumenal vesicles into late endosomes is regulated by Alix and Tsg101. Mol Biol Cell (2008) 1.45
Ubiquitin binding by a variant Jab1/MPN domain in the essential pre-mRNA splicing factor Prp8p. RNA (2006) 1.43
Efficient cargo sorting by ESCRT-I and the subsequent release of ESCRT-I from multivesicular bodies requires the subunit Mvb12. Mol Biol Cell (2006) 1.42
The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J Virol (2010) 1.42
SCAMP3 negatively regulates epidermal growth factor receptor degradation and promotes receptor recycling. Mol Biol Cell (2009) 1.39
Doa1 is a Cdc48 adapter that possesses a novel ubiquitin binding domain. Mol Cell Biol (2006) 1.39
Intracellular trafficking and maturation of herpes simplex virus type 1 gB and virus egress require functional biogenesis of multivesicular bodies. J Virol (2007) 1.33
Atomic force microscopy investigation of human immunodeficiency virus (HIV) and HIV-infected lymphocytes. J Virol (2003) 1.32
Human pathogens and the host cell SUMOylation system. J Virol (2011) 1.31
Configurational entropy in protein-peptide binding: computational study of Tsg101 ubiquitin E2 variant domain with an HIV-derived PTAP nonapeptide. J Mol Biol (2009) 1.26
No exit: targeting the budding process to inhibit filovirus replication. Antiviral Res (2008) 1.18
The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101. Traffic (2005) 1.16
Lysines close to the Rous sarcoma virus late domain critical for budding. J Virol (2004) 1.16
The ESCRT-associated protein Alix recruits the ubiquitin ligase Nedd4-1 to facilitate HIV-1 release through the LYPXnL L domain motif. J Virol (2010) 1.14
Functional replacement of a retroviral late domain by ubiquitin fusion. Traffic (2008) 1.14
The ESCRT machinery: from the plasma membrane to endosomes and back again. Crit Rev Biochem Mol Biol (2014) 1.12
Solution structure of the ubiquitin-associated domain of human BMSC-UbP and its complex with ubiquitin. Protein Sci (2006) 1.12
Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1. J Virol (2005) 1.11
Functional analysis of late-budding domain activity associated with the PSAP motif within the vesicular stomatitis virus M protein. J Virol (2004) 1.10
Regulation of Tsg101 expression by the steadiness box: a role of Tsg101-associated ligase. Mol Biol Cell (2007) 1.10
Charcot-Marie-Tooth disease-linked protein SIMPLE functions with the ESCRT machinery in endosomal trafficking. J Cell Biol (2012) 1.10
Functional interchangeability of late domains, late domain cofactors and ubiquitin in viral budding. PLoS Pathog (2010) 1.10
HIV type 1 Gag as a target for antiviral therapy. AIDS Res Hum Retroviruses (2011) 1.08
Proline-rich regions and motifs in trafficking: from ESCRT interaction to viral exploitation. Traffic (2011) 1.08
Structural basis for non-covalent interaction between ubiquitin and the ubiquitin conjugating enzyme variant human MMS2. J Biomol NMR (2006) 1.07
Crystallographic and functional analysis of the ESCRT-I /HIV-1 Gag PTAP interaction. Structure (2010) 1.04
Molecular characterization of feline immunodeficiency virus budding. J Virol (2007) 1.04
The penta-EF-hand protein ALG-2 interacts directly with the ESCRT-I component TSG101, and Ca2+-dependently co-localizes to aberrant endosomes with dominant-negative AAA ATPase SKD1/Vps4B. Biochem J (2005) 0.99
After Hrs with HIV. J Cell Biol (2003) 0.99
Ubiquitin conjugation to Gag is essential for ESCRT-mediated HIV-1 budding. Retrovirology (2013) 0.98
Role of the TSG101 gene in Epstein-Barr virus late gene transcription. J Virol (2006) 0.98
Membrane protein targeting to the MVB/lysosome. Chem Rev (2009) 0.95
The Mechanism of Budding of Retroviruses From Cell Membranes. Adv Virol (2009) 0.94
Multifunctional nature of the arenavirus RING finger protein Z. Viruses (2012) 0.92
Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1. J Virol (2006) 0.92
Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly. Retrovirology (2011) 0.90
L-domain flanking sequences are important for host interactions and efficient budding of vesicular stomatitis virus recombinants. J Virol (2005) 0.90
SAR by oxime-containing peptide libraries: application to Tsg101 ligand optimization. Chembiochem (2008) 0.90
Refined study of the interaction between HIV-1 p6 late domain and ALIX. Retrovirology (2008) 0.89
Vesicle formation within endosomes: An ESCRT marks the spot. Commun Integr Biol (2012) 0.88
Evidence for selection at HIV host susceptibility genes in a West Central African human population. BMC Evol Biol (2012) 0.87
A connected set of genes associated with programmed cell death implicated in controlling the hypersensitive response in maize. Genetics (2012) 0.87
Vesicular transport of progeny parvovirus particles through ER and Golgi regulates maturation and cytolysis. PLoS Pathog (2013) 0.86
Crystal structure of subunit VPS25 of the endosomal trafficking complex ESCRT-II. BMC Struct Biol (2004) 0.86
Whole genomes of Chandipura virus isolates and comparative analysis with other rhabdoviruses. PLoS One (2012) 0.85
Oxime-based linker libraries as a general approach for the rapid generation and screening of multidentate inhibitors. Nat Protoc (2012) 0.85
Proline-rich sequence recognition: II. Proteomics analysis of Tsg101 ubiquitin-E2-like variant (UEV) interactions. Mol Cell Proteomics (2009) 0.85
A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress. J Virol (2014) 0.83
Arenavirus budding: a common pathway with mechanistic differences. Viruses (2013) 0.83
Recruitment of Uev1B to Hrs-containing endosomes and its effect on endosomal trafficking. Exp Cell Res (2010) 0.83
Identification of late assembly domains of the human endogenous retrovirus-K(HML-2). Retrovirology (2013) 0.80
The ubiquitin-conjugating system: multiple roles in viral replication and infection. Cells (2014) 0.79
The enzymes in ubiquitin-like post-translational modifications. Biosci Trends (2007) 0.79
Constitutively active ESCRT-II suppresses the MVB-sorting phenotype of ESCRT-0 and ESCRT-I mutants. Mol Biol Cell (2014) 0.79
Identification of TSG101 functional domains and p21 loci required for TSG101-mediated p21 gene regulation. PLoS One (2013) 0.79
Miniature protein ligands for EVH1 domains: interplay between affinity, specificity, and cell motility. Biochemistry (2007) 0.78
Effects of mutant ubiquitin on ts1 retrovirus-mediated neuropathology. J Virol (2003) 0.77
Nedd4-mediated increase in HIV-1 Gag and Env proteins and immunity following DNA-vaccination of BALB/c mice. PLoS One (2014) 0.77
FYVE1/FREE1 Interacts with the PYL4 ABA Receptor and Mediates its Delivery to the Vacuolar Degradation Pathway. Plant Cell (2016) 0.77
Targeting human immunodeficiency virus type 1 assembly, maturation and budding. Drug Target Insights (2007) 0.77
Distal leucines are key functional determinants of Alix-binding simian immunodeficiency virus SIV(smE543) and SIV(mac239) type 3 L domains. J Virol (2011) 0.77
Quinoxaline-based inhibitors of Ebola and Marburg VP40 egress. Bioorg Med Chem Lett (2016) 0.76
Exploiting image registration for automated resonance assignment in NMR. J Biomol NMR (2015) 0.75
Tumor susceptibility gene 101, TSG101, REGULATES predisposition towards apoptosis VIA ESCRT machinery accessory Proteins. Mol Biol Cell (2017) 0.75
Structural Stability of the coiled-coil domain of Tumor Susceptibility Gene (TSG)-101. Biochemistry (2017) 0.75
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
The ubiquitin system. Annu Rev Biochem (1998) 43.36
MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph (1996) 39.73
Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins (1991) 36.69
AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR (1996) 29.55
Torsion angle dynamics for NMR structure calculation with the new program DYANA. J Mol Biol (1997) 15.40
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell (2001) 12.00
An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J Mol Graph Model (1997) 11.53
Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A (1991) 10.05
Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell (2001) 9.08
HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med (2001) 8.38
Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell (2000) 7.82
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol (1995) 6.87
Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell (1999) 6.56
A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins. Nature (2002) 6.22
Backbone 1H and 15N resonance assignments of the N-terminal SH3 domain of drk in folded and unfolded states using enhanced-sensitivity pulsed field gradient NMR techniques. J Biomol NMR (1994) 6.06
Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci U S A (2001) 5.83
A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci U S A (2000) 5.30
Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J Magn Reson B (1995) 4.93
Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci U S A (2000) 4.31
Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science (1999) 4.21
A role for ubiquitin ligase recruitment in retrovirus release. Proc Natl Acad Sci U S A (2000) 4.19
Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic (2000) 4.17
Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc Natl Acad Sci U S A (2002) 4.14
Ubiquitin is part of the retrovirus budding machinery. Proc Natl Acad Sci U S A (2000) 3.83
Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila. Cell (2002) 3.72
Phox domain interaction with PtdIns(3)P targets the Vam7 t-SNARE to vacuole membranes. Nat Cell Biol (2001) 3.14
Molecular insights into polyubiquitin chain assembly: crystal structure of the Mms2/Ubc13 heterodimer. Cell (2001) 3.09
Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc Natl Acad Sci U S A (2001) 3.04
TSG101/mammalian VPS23 and mammalian VPS28 interact directly and are recruited to VPS4-induced endosomes. J Biol Chem (2000) 2.69
Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J Virol (2001) 2.66
Measurement of HN-H alpha J couplings in calcium-free calmodulin using new 2D and 3D water-flip-back methods. J Biomol NMR (1994) 2.50
Structure of a conjugating enzyme-ubiquitin thiolester intermediate reveals a novel role for the ubiquitin tail. Structure (2001) 2.48
A new ticket for entry into budding vesicles-ubiquitin. Cell (2001) 2.38
A rapid and efficient one-tube PCR-based mutagenesis technique using Pfu DNA polymerase. Nucleic Acids Res (1994) 2.35
Crystal structure of the human ubiquitin conjugating enzyme complex, hMms2-hUbc13. Nat Struct Biol (2001) 2.34
Ubiquitination of HIV-1 and MuLV Gag. Virology (2000) 2.33
Ubiquitin in avian leukosis virus particles. Virology (1990) 2.13
Ubiquitin in retrovirus assembly: actor or bystander? Proc Natl Acad Sci U S A (2000) 2.08
Membrane transport: ubiquitylation in endosomal sorting. Curr Biol (2001) 2.07
Late endosomes: sorting and partitioning in multivesicular bodies. Traffic (2001) 1.89
Crystal structure of murine/human Ubc9 provides insight into the variability of the ubiquitin-conjugating system. J Biol Chem (1997) 1.71
Absence of a stable intermediate on the folding pathway of protein A. Protein Sci (1997) 1.71
TSG101 may be the prototype of a class of dominant negative ubiquitin regulators. Nat Genet (1997) 1.66
The breast cancer gene product TSG101: a regulator of ubiquitination? J Mol Med (Berl) (1997) 1.64
TSG101 protein steady-state level is regulated posttranslationally by an evolutionarily conserved COOH-terminal sequence. Cancer Res (2000) 1.43
Characterization of the binding interface between ubiquitin and class I human ubiquitin-conjugating enzyme 2b by multidimensional heteronuclear NMR spectroscopy in solution. J Mol Biol (1999) 1.25
Crystal structure of a class I ubiquitin conjugating enzyme (Ubc7) from Saccharomyces cerevisiae at 2.9 angstroms resolution. Biochemistry (1997) 1.20
Tertiary structures of class I ubiquitin-conjugating enzymes are highly conserved: crystal structure of yeast Ubc4. Biochemistry (1993) 1.18
Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag). J Virol (2001) 1.14
Three-dimensional structure of a ubiquitin-conjugating enzyme (E2). J Biol Chem (1992) 1.14
Crystal structure of the Saccharomyces cerevisiae ubiquitin-conjugating enzyme Rad6 at 2.6 A resolution. J Biol Chem (1998) 1.06
Hrs and hbp: possible regulators of endocytosis and exocytosis. Biochem Biophys Res Commun (2001) 0.91
Connexin and gap junction degradation. Methods (2000) 0.89
Defining polyubiquitin chain topology. Nat Struct Biol (2001) 0.86
Crystal structure of the cyclin-specific ubiquitin-conjugating enzyme from clam, E2-C, at 2.0 A resolution. Biochemistry (1999) 0.83
The protein network of HIV budding. Cell (2003) 7.82
Retrovirus budding. Annu Rev Cell Dev Biol (2004) 7.16
Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci U S A (2006) 6.82
Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. EMBO J (2007) 5.31
Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J Virol (2002) 5.20
Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol (2003) 4.47
An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe (2007) 4.17
X-ray structures of the hexameric building block of the HIV capsid. Cell (2009) 4.08
The structural biology of HIV assembly. Curr Opin Struct Biol (2008) 3.71
Global landscape of HIV-human protein complexes. Nature (2011) 3.70
ESCRT-III recognition by VPS4 ATPases. Nature (2007) 3.64
Mechanisms of enveloped RNA virus budding. Trends Cell Biol (2002) 3.36
The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell (2003) 3.36
Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'. J Mol Recognit (2009) 3.25
Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. EMBO J (2007) 3.17
Assembly properties of the human immunodeficiency virus type 1 CA protein. J Virol (2004) 3.09
Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell (2007) 3.06
The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell (2007) 2.99
E2 interaction and dimerization in the crystal structure of TRAF6. Nat Struct Mol Biol (2009) 2.79
Ubiquitin interactions of NZF zinc fingers. EMBO J (2004) 2.72
Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat Struct Biol (2002) 2.66
ESCRT-III protein requirements for HIV-1 budding. Cell Host Microbe (2011) 2.61
Structural and mechanistic studies of VPS4 proteins. EMBO J (2005) 2.58
Hexagonal assembly of a restricting TRIM5alpha protein. Proc Natl Acad Sci U S A (2010) 2.40
HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. J Cell Biol (2003) 2.38
Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J Virol (2004) 2.37
Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication. J Virol (2008) 2.30
Analyzing a kinetic titration series using affinity biosensors. Anal Biochem (2005) 2.27
Two distinct modes of ESCRT-III recognition are required for VPS4 functions in lysosomal protein targeting and HIV-1 budding. Dev Cell (2008) 2.23
Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A. Proc Natl Acad Sci U S A (2002) 2.19
Structure and ubiquitin binding of the ubiquitin-interacting motif. J Biol Chem (2003) 2.19
Identification of human MVB12 proteins as ESCRT-I subunits that function in HIV budding. Cell Host Microbe (2007) 2.18
Direct comparison of binding equilibrium, thermodynamic, and rate constants determined by surface- and solution-based biophysical methods. Protein Sci (2002) 2.13
Structure and ESCRT-III protein interactions of the MIT domain of human VPS4A. Proc Natl Acad Sci U S A (2005) 2.12
Three-dimensional structure of HIV-1 virus-like particles by electron cryotomography. J Mol Biol (2004) 2.10
Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release. J Virol (2006) 2.06
Structural basis for ESCRT-III protein autoinhibition. Nat Struct Mol Biol (2009) 1.98
The human endosomal sorting complex required for transport (ESCRT-I) and its role in HIV-1 budding. J Biol Chem (2004) 1.92
ALIX-CHMP4 interactions in the human ESCRT pathway. Proc Natl Acad Sci U S A (2008) 1.91
Membrane fission reactions of the mammalian ESCRT pathway. Annu Rev Biochem (2013) 1.91
Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance. Proc Natl Acad Sci U S A (2010) 1.89
Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol (2005) 1.88
CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature (2012) 1.85
Yeast frataxin solution structure, iron binding, and ferrochelatase interaction. Biochemistry (2004) 1.80
Kinetic analysis of beta-amyloid fibril elongation. Anal Biochem (2004) 1.78
Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein. J Mol Biol (2007) 1.78
Structural insights into the catalytic mechanism of cyclophilin A. Nat Struct Biol (2003) 1.78
Structural and functional studies of ALIX interactions with YPX(n)L late domains of HIV-1 and EIAV. Nat Struct Mol Biol (2007) 1.76
The role of LIP5 and CHMP5 in multivesicular body formation and HIV-1 budding in mammalian cells. J Biol Chem (2005) 1.73
Structure and ubiquitin interactions of the conserved zinc finger domain of Npl4. J Biol Chem (2003) 1.72
Virus budding and the ESCRT pathway. Cell Host Microbe (2013) 1.70
Exploring "one-shot" kinetics and small molecule analysis using the ProteOn XPR36 array biosensor. Anal Biochem (2006) 1.62
NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. J Virol (2008) 1.60
Three-dimensional structure of the M-MuLV CA protein on a lipid monolayer: a general model for retroviral capsid assembly. EMBO J (2003) 1.58
Biochemical analyses of human IST1 and its function in cytokinesis. Mol Biol Cell (2009) 1.57
Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac. J Biol Chem (2003) 1.54
Higher-throughput, label-free, real-time molecular interaction analysis. Anal Biochem (2006) 1.47
Structural effects of hypermodified nucleosides in the Escherichia coli and human tRNALys anticodon loop: the effect of nucleosides s2U, mcm5U, mcm5s2U, mnm5s2U, t6A, and ms2t6A. Biochemistry (2005) 1.45
Implications for viral capsid assembly from crystal structures of HIV-1 Gag(1-278) and CA(N)(133-278). Biochemistry (2006) 1.41
Structural basis for ubiquitin recognition by the human ESCRT-II EAP45 GLUE domain. Nat Struct Mol Biol (2006) 1.41
Solubilization, stabilization, and purification of chemokine receptors using biosensor technology. Anal Biochem (2005) 1.36
Cryo-EM structure of dodecameric Vps4p and its 2:1 complex with Vta1p. J Mol Biol (2008) 1.33
Survey of the year 2007 commercial optical biosensor literature. J Mol Recognit (2008) 1.32
Kinetic analysis of a high-affinity antibody/antigen interaction performed by multiple Biacore users. Anal Biochem (2006) 1.31
Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations. Proc Natl Acad Sci U S A (2010) 1.29
The tripartite motif coiled-coil is an elongated antiparallel hairpin dimer. Proc Natl Acad Sci U S A (2014) 1.27
Molecular basis for passive immunotherapy of Alzheimer's disease. Proc Natl Acad Sci U S A (2007) 1.26
Kinetic analysis of estrogen receptor/ligand interactions. Proc Natl Acad Sci U S A (2002) 1.26
Extracting kinetic rate constants from surface plasmon resonance array systems. Anal Biochem (2007) 1.21
Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes. Antimicrob Agents Chemother (2013) 1.18
Characterizing high-affinity antigen/antibody complexes by kinetic- and equilibrium-based methods. Anal Biochem (2004) 1.18
Structural models for interactions between the 20S proteasome and its PAN/19S activators. J Biol Chem (2009) 1.17
Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein. J Virol (2012) 1.17
The Polycomb-associated protein Rybp is a ubiquitin binding protein. FEBS Lett (2006) 1.16
Survey of the 2009 commercial optical biosensor literature. J Mol Recognit (2011) 1.15
Biochemical and structural studies of yeast Vps4 oligomerization. J Mol Biol (2008) 1.15
Screening antibody-antigen interactions in parallel using Biacore A100. Anal Biochem (2006) 1.14
Good to CU. Nature (2003) 1.13
Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology. Anal Biochem (2006) 1.13
Comparative analysis of 10 small molecules binding to carbonic anhydrase II by different investigators using Biacore technology. Anal Biochem (2006) 1.11
Inhibitor-induced structural change in the HCV IRES domain IIa RNA. Proc Natl Acad Sci U S A (2010) 1.10
Survey of the year 2003 commercial optical biosensor literature. J Mol Recognit (2004) 1.09
Thermodynamic benchmark study using Biacore technology. Anal Biochem (2007) 1.07